Diagnostic company Genes2Me on Tuesday announced that it has developed a real-time PCR-based kit for monkeypox virus.
The Company Claimed That Its POX-Q Multiplexed RT-PCR Kit Gives Results in Less Than 50 Minutes With A High Frequency Rate
Neeraj Gupta, CEO and Founder, Genes2me, said in a statement, “This unprecedented time underscores the importance of clinical assays in healthcare preparedness and preparedness.
Understanding the value of time, we have launched this RT PCR for monkeypox, Which will give results in less than 50 minutes with highest accuracy.
Gupta mentioned that the company currently has a capacity to manufacture 50 lakh test kits a week and this can be scaled up to 20 lakh tests a day with additional demand.
So far more than 16,000 cases of monkeypox have been reported from 75 countries. Four patients of this virus have also been found in India.
The World Health Organization (WHO) has declared the outbreak a public health emergency of international concern.
The WHO recommends that the specimen type for laboratory confirmation of monkeypox is skin lesion material, including the wound surface and/or exudate, multiple lesion layers, or wound crusts.
Therefore, for monkeypox detection, both dry swabs and swabs placed in VTM or viral transport medium – a solution used to preserve virus samples after collection – can be used. could.
The kit is available in both a standard version for any commonly available RT-PCR equipment as well as a point-of-care format on the Genesus2m Rapi-Q HT Rapid RT-PCR device.
The point-of-care solution can be used for screening at multiple sites including hospitals, airports, diagnostic laboratories, health camps, the company said.